SANIA THERAPEUTICS, INC. — Form D
SANIA THERAPEUTICS, INC. of LONDON, X0, a company, filed a Form D exempt-offering notice with the SEC on 2024-05-21. The offering totals $7.5M, of which $5.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-05-21
- Form: D
- Accession: 0001901599-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $7.5M
- Amount sold: $5.0M
- Remaining: $2.5M
- Investors: 4
- Date of first sale: 2024-05-06
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-513793
Issuer
- Name: SANIA THERAPEUTICS, INC.
- CIK: 0001901599
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: C/O SANIA RX LTD, WATERFRONT BUILDING, LONDON, X0, W6 9RH
- Phone: 011442033988924
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Robert Brownstone | Director | London, X0 |
| Mark Evans | Director | Newport Beach, X1 |
| Joseph Korff | Director | London, X0 |
| Andrew Murray | Director | London, X0 |
| Andrew Murray | Executive Officer | London, X0 |
| Robert Brownstone | Executive Officer | London, X0 |
| Eric Kohlmann | Director | New York, NY |
| Raj Dattani | Director | London, X0 |
| Raj Dattani | Executive Officer | London, X0 |
Other filings by this issuer (2)
More